[go: up one dir, main page]

AU5270796A - N-substituted azaheterocyclic carboxylic acids and esters th ereof - Google Patents

N-substituted azaheterocyclic carboxylic acids and esters th ereof

Info

Publication number
AU5270796A
AU5270796A AU52707/96A AU5270796A AU5270796A AU 5270796 A AU5270796 A AU 5270796A AU 52707/96 A AU52707/96 A AU 52707/96A AU 5270796 A AU5270796 A AU 5270796A AU 5270796 A AU5270796 A AU 5270796A
Authority
AU
Australia
Prior art keywords
ereof
esters
carboxylic acids
substituted azaheterocyclic
azaheterocyclic carboxylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52707/96A
Inventor
Henrik Sune Andersen
Knud Erik Andersen
Rolf Hohlweg
Tine Krogh Jorgensen
Peter Madsen
Uffe Bang Olsen
Hans Petersen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU5270796A publication Critical patent/AU5270796A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU52707/96A 1995-04-07 1996-04-01 N-substituted azaheterocyclic carboxylic acids and esters th ereof Abandoned AU5270796A (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
DK40895 1995-04-07
DK40295 1995-04-07
DK408/95 1995-04-07
DK40495 1995-04-07
DK402/95 1995-04-07
DK404/95 1995-04-07
DK100795 1995-09-11
DK100495 1995-09-11
DK1007/95 1995-09-11
DK1004/95 1995-09-11
PCT/DK1996/000142 WO1996031469A1 (en) 1995-04-07 1996-04-01 N-substituted azaheterocyclic carboxylic acids and esters thereof

Publications (1)

Publication Number Publication Date
AU5270796A true AU5270796A (en) 1996-10-23

Family

ID=27512777

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52707/96A Abandoned AU5270796A (en) 1995-04-07 1996-04-01 N-substituted azaheterocyclic carboxylic acids and esters th ereof

Country Status (3)

Country Link
AU (1) AU5270796A (en)
IL (1) IL117817A0 (en)
WO (1) WO1996031469A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323206B1 (en) 1996-07-12 2001-11-27 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
AU729415B2 (en) 1996-07-12 2001-02-01 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
EP1049700B9 (en) 1998-01-21 2006-05-10 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
AU2335699A (en) 1998-01-21 1999-08-09 Kyowa Hakko Kogyo Co. Ltd. Chemokine receptor antagonists and methods of use therefor
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
EA008060B1 (en) * 1998-09-04 2007-02-27 Милленниум Фармасьютикалз, Инк. Chemokine receptor antagonists and methods of use thereof
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6593337B1 (en) 1999-10-19 2003-07-15 Bristol-Myers Squibb Pharma Company Tricyclic compounds useful as HIV reverse transcriptase inhibitors
WO2002085365A1 (en) 2001-04-19 2002-10-31 Bristol-Myers Squibb Company Tricyclic compounds useful as hiv reverse transcriptase inhibitors
US7355042B2 (en) 2001-10-16 2008-04-08 Hypnion, Inc. Treatment of CNS disorders using CNS target modulators
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
PL403800A1 (en) * 2001-11-21 2013-08-19 Millennium Pharmaceuticals, Inc. Pharmaceutical composition
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2945031A (en) * 1958-10-13 1960-07-12 Smith Kline French Lab Methylenedioxy substituted phenothiazines
US3010961A (en) * 1959-01-21 1961-11-28 Geigy Chem Corp Basically substituted derivatives of 11 hquinoxalino [2.3-b]-p-benzothiazines
CH421111A (en) * 1961-07-12 1966-09-30 Degussa Process for the preparation of derivatives of the 4-azaphenthiazines
DE1166206B (en) * 1962-04-11 1964-03-26 Degussa Process for the preparation of 4-azaphenthiazine derivatives
GB1242096A (en) * 1968-12-20 1971-08-11 Labaz Benzobenzofuranooxepine compounds and process for preparing the same

Also Published As

Publication number Publication date
IL117817A0 (en) 1996-08-04
WO1996031469A1 (en) 1996-10-10

Similar Documents

Publication Publication Date Title
AU5270796A (en) N-substituted azaheterocyclic carboxylic acids and esters th ereof
HUP9800719A3 (en) N-substituted azaheterocyclic carboxylic acids and esters, process for producing them, use and pharmaceutical compositions containing the same
AU5556396A (en) Hydroxamic and carboxylic acids as metalloprotease inhibitor s
AU5727296A (en) 2-carbocyclic and 2-heterocyclic quinoline-4-carboxylic acids and salts thereof useful as immunosuppressive agents
HUP9801156A3 (en) Carbapenem-3-carboxylic acid ester derivatives
AU5746496A (en) Benzisoxazole and indazole derivatives as antipsychotic agents
HUP9900911A3 (en) Esters and amides as pla2 inhibitors
ZA963397B (en) Esters and pharmaceutical compositions
HU9503755D0 (en) N-substituted azaheterocyclic carboxylic acids and esters thereof
AU1064895A (en) 3-methoxy-phenyl-acrylic acid methyl esters
AU6926294A (en) Carboxylic acid amide benzothiophene-s-oxides
AU7534894A (en) 3-methoxy-2-phenylacrylic acid methyl esters
EP0831095A3 (en) Process for the preparation of dicetopyrrolopyrrole carboxylic acids, their esters and amides
HUP9802329A3 (en) Carboxylic acid derivatives
AU4981693A (en) Optically active carboxamide derivative
HU9503752D0 (en) N-substituted azaheterocyclic carboxylic acids and esters thereof
AU6354696A (en) Carboxylic acid amide derivatives and their use as pesticides
AU7290096A (en) Substituted benzylidenecyanoacetic esters
PL323148A1 (en) Esters of crabapenemes
HU9503754D0 (en) N-substituted azaheterocyclic carboxylic acids and esters thereof
HU9503753D0 (en) N-substituted azaheterocyclic carboxylic acids and esters thereof
PL324340A1 (en) Novel quinoxalinophosphonic and quinoxalinoalkanophosphonic acids
PL323141A1 (en) Esters of crabapenemes
HK1009799A (en) Esters and amides as pla2 inhibitors
AU689443C (en) Trifluoromethylpyrroloindole carboxylic ester derivative and process for producing the same